News

Metabolic screening and treatment preferences of Hispanic inpatients.

C Mangurian , E Goss , J Newcomer 

Primary Care Providers’ Views on Metabolic Monitoring of Outpatients Taking Antipsychotic Medication

C Mangurian, F Giwa,  M Shumway, E Fuentes-Afflick, E Perez-Stable,  J Dilley, D Schillinger

Addressing cardiometabolic risk during treatment with antipsychotic medications.

J Amiel, C Mangurian, J Newcomer 

Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists.

Parameswaran S., Chang C., Mangurian C.   Abstract  Premature mortality for people with serious mental illness (SMI) is impacted by under-treatment of cardiovascular risk factors and metabolic effects of antipsychotic medications (Daumit et al., 2008; Nasrallah et al., 2006).

Obesity Treatment for Urban, Low-Income Latinos with Severe Mental Illness

C Mangurian, M Stowe, M Delvin

Physical health screening in state mental health clinics: The New York Health Indicators Initiative.

C Mangurian, G Miller, C Jackson, H Li, S Essock, L Sederer   Abstract